4204 — Sekisui Chemical Co Balance Sheet
0.000.00%
- ¥1tn
- ¥1tn
- ¥1tn
- 89
- 62
- 89
- 95
Annual balance sheet for Sekisui Chemical Co, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | Yuho | Yuho | Yuho | Yuho | Tanshin |
Standards: | JAS | JAS | JAS | JAS | — |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 87,454 | 144,534 | 101,080 | 138,572 | 142,586 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 169,461 | 185,393 | 191,681 | 213,798 | 207,566 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 505,571 | 609,395 | 621,650 | 685,564 | 703,104 |
Net Property, Plant And Equipment | 351,397 | 365,254 | 377,381 | 392,485 | 403,870 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 1,150,143 | 1,198,921 | 1,228,131 | 1,323,243 | 1,330,786 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 282,278 | 329,694 | 327,978 | 344,597 | 340,002 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 483,076 | 524,284 | 523,104 | 530,913 | 523,439 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Unrealized Gain / Loss | |||||
Other Equity | |||||
Total Equity | 667,067 | 674,637 | 705,027 | 792,330 | 807,347 |
Total Liabilities & Shareholders' Equity | 1,150,143 | 1,198,921 | 1,228,131 | 1,323,243 | 1,330,786 |
Total Common Shares Outstanding |